SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 177 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $40,000 | +53.8% | 3,800 | -63.8% | 0.00% | +100.0% |
| Q4 2020 | $26,000 | -21.2% | 10,500 | -42.6% | 0.00% | -50.0% |
| Q4 2019 | $33,000 | +1000.0% | 18,300 | +553.6% | 0.00% | – |
| Q2 2019 | $3,000 | – | 2,800 | +250.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 800 | -88.2% | 0.00% | – |
| Q4 2018 | $5,000 | -68.8% | 6,800 | +70.0% | 0.00% | -100.0% |
| Q3 2018 | $16,000 | +60.0% | 4,000 | +48.1% | 0.00% | 0.0% |
| Q2 2018 | $10,000 | – | 2,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |